close
MENU
Hot Topic EARNINGS
Hot Topic EARNINGS
3 mins to read

Pacific Edge moves cancer test kit sales online as it pushes for $100m target

Calida Smylie
Wed, 09 Jul 2014

A New Zealand maker of non-invasive bladder cancer test kits hopes that making its technology available online will help it reach its target of $100 million per year sales revenue.

Cancer diagnostic developer and service provider Pacific Edge [NZX:PEB] is launching an e-commerce site later

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Smartphone Only Annual Subscription

NZ$249.00 / yearly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Subscription

NZ$29.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Calida Smylie
Wed, 09 Jul 2014
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Pacific Edge moves cancer test kit sales online as it pushes for $100m target
39470
true